Candel Therapeutics, Inc.
CADL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $274,940 | $42,535 | $51,594 | $224,355 |
| - Cash | $102,654 | $35,413 | $70,058 | $82,642 |
| + Debt | $13,471 | $22,762 | $22,800 | $560 |
| Enterprise Value | $185,757 | $29,884 | $4,336 | $142,273 |
| Revenue | $0 | $0 | $125 | $125 |
| % Growth | – | -100% | 0% | – |
| Gross Profit | -$990 | -$23,980 | $125 | -$14,469 |
| % Margin | – | – | 100% | -11,575.2% |
| EBITDA | -$52,097 | -$37,431 | -$16,308 | -$25,494 |
| % Margin | – | – | -13,046.4% | -20,395.2% |
| Net Income | -$55,177 | -$37,939 | -$18,794 | -$36,124 |
| % Margin | – | – | -15,035.2% | -28,899.2% |
| EPS Diluted | -1.74 | -1.31 | -0.099 | -1.26 |
| % Growth | -32.8% | -1,217.9% | 92.1% | – |
| Operating Cash Flow | -$27,023 | -$34,244 | -$31,419 | -$22,218 |
| Capital Expenditures | -$16 | -$457 | -$1,297 | -$1,835 |
| Free Cash Flow | -$27,039 | -$34,701 | -$32,716 | -$24,053 |